4.6 Article

Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore

Journal

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpheart.01012.2008

Keywords

mitochondria; mitochondrial permeability transition pore; polyol pathway

Funding

  1. National Institutes of Health [HL61783, HL68954, HL60901]
  2. Juvenile Diabetes Research Foundation

Ask authors/readers for more resources

Ananthakrishnan R, Kaneko M, Hwang YC, Quadri N, Gomez T, Li Q, Caspersen C, Ramasamy R. Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore. Am J Physiol Heart Circ Physiol 296: H333-H341, 2009. First published December 5, 2008; doi:10.1152/ajpheart.01012.2008.-Aldose reductase (AR), a member of the aldo-keto reductase family, has been demonstrated to play a central role in mediating myocardial ischemia-reperfusion (I/R) injury. Recently, using transgenic mice broadly overexpressing human AR (ARTg), we demonstrated that AR is an important component of myocardial I/R injury and that inhibition of this enzyme protects heart from I/R injury (20-22, 48, 49, 56). To rigorously delineate mechanisms by which AR pathway influences myocardial ischemic injury, we investigated the role played by reactive oxygen species (ROS), antioxidant enzymes, and mitochondrial permeability transition (MPT) pore opening in hearts from ARTg or littermates [wild type (WT)] subjected to I/R. MPT pore opening after I/R was determined using mitochondrial uptake of 2-deoxyglucose ratio, while H2O2 was measured as a key indicator of ROS. Myocardial 2-deoxy-glucose uptake ratio and calcium-induced swelling were significantly greater in mitochondria from ARTg mice than in WT mice. Blockade of MPT pore with cyclosphorin A during I/R reduced ischemic injury significantly in ARTg mice hearts. H2O2 measurements indicated mitochondrial ROS generation after I/R was significantly greater in ARTg mitochondria than in WT mice hearts. Furthermore, the levels of antioxidant GSH were significantly reduced in ARTg mitochondria than in WT. Resveratrol treatment or pharmacological blockade of AR significantly reduced ROS generation and MPT pore opening in mitochondria of ARTg mice hearts exposed to I/R stress. This study demonstrates that MPT pore opening is a key event by which AR pathway mediates myocardial I/R injury, and that the MPT pore opening after I/R is triggered, in part, by increases in ROS generation in ARTg mice hearts. Therefore, inhibition of AR pathway protects mitochondria and hence may be a useful adjunct for salvaging ischemic myocardium.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Biochemical Research Methods

The receptor for advanced glycation end products (RAGE) and DIAPH1: unique mechanisms and healing the wounded vascular system

Ravichandran Ramasamy, Richard A. Friedman, Alexander Shekhtman, Ann Marie Schmidt

EXPERT REVIEW OF PROTEOMICS (2019)

Editorial Material Cardiac & Cardiovascular Systems

Significance and Mechanistic Relevance of SIRT6-Mediated Endothelial Dysfunction in Cardiovascular Disease Progression

Gautham Yepuri, Ravichandran Ramasamy

CIRCULATION RESEARCH (2019)

Editorial Material Hematology

Metabolism, Obesity, and Diabetes Mellitus Recent Studies in Cellular and Animal Models and Human Subjects Highlight Mechanisms and Consequences of Metabolic Dysfunction

Henry H. Ruiz, Raquel Lopez Diez, Lakshmi Arivazahagan, Ravichandran Ramasamy, Ann Marie Schmidt

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)

Article Biochemistry & Molecular Biology

The Receptor for Advanced Glycation End Products (RAGE) and DIAPH1: Implications for vascular and neuroinflammatory dysfunction in disorders of the central nervous system

Michael MacLean, Julia Derk, Henry H. Ruiz, Judyta K. Juranek, Ravichandran Ramasamy, Ann Marie Schmidt

NEUROCHEMISTRY INTERNATIONAL (2019)

Meeting Abstract Cardiac & Cardiovascular Systems

Preclinical and Clinical Proof of Concept for Metabolic Intervention in Diabetic Cardiomyopathy

Riccardo Perfetti, Philana Rowell, Shoshana Shendelman, Francesca Lawson, Ravichandran Ramasamy

JOURNAL OF CARDIAC FAILURE (2019)

Review Endocrinology & Metabolism

Advanced Glycation End Products: Building on the Concept of the Common Soil in Metabolic Disease

Henry H. Ruiz, Ravichandran Ramasamy, Ann Marie Schmidt

ENDOCRINOLOGY (2020)

Meeting Abstract Endocrinology & Metabolism

Overcoming the Safety Challenges of Aldose Reductase Inhibition: Development of AT-001 for Diabetic Cardiomyopathy

R. Perfetti, G. Yeppuri, N. Quadri, R. Ramasamy, S. Shendelman

METABOLISM-CLINICAL AND EXPERIMENTAL (2020)

Article Cardiac & Cardiovascular Systems

An Eclectic Cast of Cellular Actors Orchestrates Innate Immune Responses in the Mechanisms Driving Obesity and Metabolic Perturbation

Lakshmi Arivazhagan, Henry H. Ruiz, Robin A. Wilson, Michaele B. Manigrasso, Paul F. Gugger, Edward A. Fisher, Kathryn J. Moore, Ravichandran Ramasamy, Ann Marie Schmidt

CIRCULATION RESEARCH (2020)

Article Multidisciplinary Sciences

Enhanced glycolysis and HIF-1α activation in adipose tissue macrophages sustains local and systemic interleukin-1β production in obesity

Monika Sharma, Ludovic Boytard, Tarik Hadi, Graeme Koelwyn, Russell Simon, Mireille Ouimet, Lena Seifert, Westley Spiro, Bo Yan, Susan Hutchison, Edward A. Fisher, Ravichandran Ramasamy, Bhama Ramkhelawon, Kathryn J. Moore

SCIENTIFIC REPORTS (2020)

Review Hematology

COVID-19 and the Heart and Vasculature Novel Approaches to Reduce Virus-Induced Inflammation in Patients With Cardiovascular Disease

Bernard S. Kadosh, Michael S. Garshick, Juan Gaztanaga, Kathryn J. Moore, Jonathan D. Newman, Michael Pillinger, Ravichandran Ramasamy, Harmony R. Reynolds, Binita Shah, Judith Hochman, Glenn Fishman, Stuart D. Katz

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

Article Medicine, Research & Experimental

RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism

Laura Senatus, Raquel Lopez-Diez, Lander Egana-Gorrono, Jianhua Liu, Jiyuan Hu, Gurdip Daffu, Qing Li, Karishma Rahman, Yuliya Vengrenyuk, Tessa J. Barrett, M. Zahidunnabi Dewan, Liang Guo, Daniela Fuller, Aloke Finn, Renu Virmani, Huilin Li, Richard A. Friedman, Edward A. Fisher, Ravichandran Ramasamy, Ann Marie Schmidt

JCI INSIGHT (2020)

Review Hematology

Journey to a Receptor for Advanced Glycation End Products Connection in Severe Acute Respiratory Syndrome Coronavirus 2 Infection With Stops Along the Way in the Lung, Heart, Blood Vessels, and Adipose Tissue

Divya Roy, Ravichandran Ramasamy, Ann Marie Schmidt

Summary: The SARS-CoV-2 pandemic continues to affect millions globally, with no definitive cures or preventative measures available. Identifying the pathobiological mechanisms is urgent to understand the increased risk and severity of infection.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Diabetes and Cardiovascular Complications: The Epidemics Continue

Raquel Lopez-Diez, Lander Egana-Gorrono, Laura Senatus, Alexander Shekhtman, Ravichandran Ramasamy, Ann Marie Schmidt

Summary: This review highlights the cardiovascular complications of diabetes, efforts in glycemic control, and the potential benefits and drawbacks of intensive glycemic control. The role of epigenetics, gene expression, interferon networks, mitochondrial dysfunction in driving cardiovascular disorders in diabetes is discussed, along with updates on cardioprotective therapies for hyperglycemia. Ongoing research is providing new therapeutic opportunities in diabetes and cardiovascular diseases.

CURRENT CARDIOLOGY REPORTS (2021)

Review Cardiac & Cardiovascular Systems

Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models

Lander Egana-Gorrono, Raquel Lopez-Diez, Gautham Yepuri, Lisa S. Ramirez, Sergey Reverdatto, Paul F. Gugger, Alexander Shekhtman, Ravichandran Ramasamy, Ann Marie Schmidt

FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)

Article Endocrinology & Metabolism

Metabolic dysfunction in Emirati subjects in Abu Dhabi: Relationship to levels of soluble RAGEs

Abdishakur Abdulle, Claire K. Inman, Abdelkarim Saleh, Mohamed Noshi, Divya Galani, Laila Abdelwareth, Habiba Alsafar, Abubaker Elfatih, Hefsa Al Shamsi, Raghib Ali, Huilin Li, Ravichandran Ramasamy, Ann Marie Schmidt, Mahmoud M. Benbarka, Mohamed H. Hassan

JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY (2019)

No Data Available